Sanofi SA (NYSE:SNY)

During the Trading Day
48.80 -1.50 / -2.98%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
48.76 -0.04 / -0.08%
 
Volume: 100.2K
Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
7:27pm / Zacks.com
Sanofi Inks Multi-Component Strategic Deal with Evotec - Analyst Blog
Mar 20 / Zacks.com
Investors' Love/Hate Relationship with MannKind Corp. Stock
8:04am / MotleyFool.com
CVS Says New Cholesterol Drug Types Could Be Costly
Mar 20 / Benzinga
Is It Time for GlaxoSmithKline plc to Change Management?
Mar 25 / MotleyFool.com
Why Amicus Therapeutics, Inc. Stock Is Soaring Today
Mar 19 / MotleyFool.com
Isis Pharmaceuticals Reports Phase I Data on Lipid Candidate - Analyst Blog
Mar 24 / Zacks.com
Regeneron Hits a 52-Week High on Positive Praluent Data - Analyst Blog
Mar 18 / Zacks.com
Is This The Biggest Threat to Isis Pharmaceuticals Stock?
Mar 24 / MotleyFool.com
Pharma Stock Outlook: Let's Make a Deal - Industry Outlook
Mar 17 / Zacks.com
In Case You Missed It, This Tiny Biotech Is Poised for Explosive Growth
Mar 24 / MotleyFool.com
Pharma Stock Outlook: Let's Make a Deal - Zacks Analyst Interviews
Mar 17 / Zacks.com
3 Biotech Stocks to Buy If the Sector Crashes
Mar 23 / MotleyFool.com
Regeneron/Sanofi's PCSK9 Drug Praluent Data Published - Analyst Blog
Mar 16 / Zacks.com
Did Researchers Just Unlock a Type 1 Diabetes Cure?
Mar 22 / MotleyFool.com
Amgen Presents Encouraging PCSK9 Inhibitor Repatha Data - Analyst Blog
Mar 16 / Zacks.com
Drug Spending Is Soaring: 3 Takeaways You Can't Miss
Mar 21 / MotleyFool.com
Alnylam Announces Positive Data from Natural History Study - Analyst Blog
Mar 16 / Zacks.com
Amicus to Seek for Migalastat's Approval in the U.S., EU - Analyst Blog
Mar 20 / Zacks.com
Too Good to Be True? Proceed With Caution on These 2 Biotechs
Mar 14 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account